Bioventus (BVS)
(Delayed Data from NSDQ)
$6.18 USD
-0.34 (-5.21%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $6.18 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Bioventus Inc. has a market cap of $535.58M, which represents its share price of $6.52 multiplied by its outstanding shares number of 82.14M. As a small-cap company, BVS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BVS 6.18 -0.34(-5.21%)
Will BVS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BVS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BVS
Do Options Traders Know Something About Bioventus Stock We Don't?
Bioventus (BVS) Q1 Earnings and Revenues Surpass Estimates
BVS: What are Zacks experts saying now?
Zacks Private Portfolio Services
4 Healthcare Stocks to Buy as the Sector Faces Government Heat
Ensign Group Invests in Growth With New Facility Acquisitions
Here's Why Bioventus (BVS) Is a Great 'Buy the Bottom' Stock Now
Other News for BVS
Bioventus gets FDA nod for pain management devices
Bioventus (BVS) Gains FDA Clearance for Pain Management Devices
Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation ...
Bioventus receives FDA 510k clearances for two next-gen PNS products
Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025 | ...